Evaluating the Role of Clinical Pharmacists in Oncology: A Systematic Review of Interventions and Patient Outcomes
Abstract
Purpose: The primary goal of this review is to assess the impact of clinical pharmacists on cancer treatment outcomes, specifically focusing on patient quality of life, treatment adherence, and the reduction of adverse events. A secondary goal is to identify specific interventions or activities that have the most significant effects in cancer care settings.
Methods: Conduct a comprehensive search across databases include PubMed, Embase, Cochrane Library, and CINAHL. Use keywords like “clinical pharmacist in oncology,” “oncology pharmacist interventions,” “pharmacist role in cancer treatment,” and “patient outcomes in oncology.” This research will assist identify evidence-based approaches that improve oncology patient outcomes and advance a greater understanding of the critical role pharmacists play in cancer treatment.
Conclusion: Available evidence suggests that outpatient oncology practices may benefit from integrating pharmacists into care models in order to more effectively, efficiently, and holistically address the needs of patients with cancer.
Letters in High Energy Physics (LHEP) is an open access journal. The articles in LHEP are distributed according to the terms of the creative commons license CC-BY 4.0. Under the terms of this license, copyright is retained by the author while use, distribution and reproduction in any medium are permitted provided proper credit is given to original authors and sources.
Terms of Submission
By submitting an article for publication in LHEP, the submitting author asserts that:
1. The article presents original contributions by the author(s) which have not been published previously in a peer-reviewed medium and are not subject to copyright protection.
2. The co-authors of the article, if any, as well as any institution whose approval is required, agree to the publication of the article in LHEP.
